EUVIMEDAtrasti EUVIMED
LeserbriefOpen access · CC BY 4.0

Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis

Wenkai Fu iD, Junqi Wang iD, Nan Lu, Zhijiang Guo iD, Sang-Bing Ong iD, Yong Gao, Hao Zhou iD, Xing Chang iD, Miao Meng iD

Cell Proliferation · 2026

DOI: 10.1111/cpr.70141 ↗

At a glance

Leserbrief in Cell Proliferation, 2026. Written by Wenkai Fu and 8 co-authors. Institution: The Third School of Clinical Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China. Major MEDLINE topics: Mitochondria, Fatty Liver. Cited 4 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY 4.0).

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Mitochondrial quality control (MQC) impairment plays a central role in driving the pathogenesis of metabolism-associated steatotic liver disease (MASLD). Specifically, this is manifested as reduced mitophagy; increased mitochondrial fission and decreased fusion; and impaired mitochondrial biogenesis. Key pathological mechanisms of MASLD, such as hepatocyte apoptosis, pyroptosis, and ferroptosis, are activated under the influence of factors including free fatty acids (FFAs), oxidative stress, NLRP3 inflammasome activation, and gut microbiota imbalance. Meanwhile, the letter also lists novel potential therapeutic strategies targeting these pathways, including autophagy enhancers, mitochondrial dynamics regulators, biogenesis promoters, and ferroptosis inhibitors.

Subjects

MeSH terms (MEDLINE)

MitochondriaFatty LiverHumansMitochondrial DynamicsAnimalsMitophagyOxidative Stress

Authors and institutions

  • The Third School of Clinical Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China.
  • Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Cardiology, Senior Department of Cardiology, PLA General Hospital, Beijing, China.
  • Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Gastroenterology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

ORCID profiles: Wenkai Fu, Junqi Wang, Zhijiang Guo, Sang-Bing Ong, Hao Zhou, Xing Chang, Miao Meng

Cite

APA

Fu, W., Wang, J., Lu, N., Guo, Z., Ong, S. B., Gao, Y., Zhou, H., Chang, X., & Meng, M. (2026). Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis. Cell Proliferation. https://doi.org/10.1111/cpr.70141

Vancouver

Fu W, Wang J, Lu N, Guo Z, Ong SB, Gao Y, et al. Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis. Cell Proliferation. 2026. doi:10.1111/cpr.70141

BibTeX
@article{Fu2026,
  author = {Fu, Wenkai and Wang, Junqi and Lu, Nan and Guo, Zhijiang and Ong, Sang-Bing and Gao, Yong and Zhou, Hao and Chang, Xing and Meng, Miao},
  title = {Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis},
  journal = {Cell Proliferation},
  year = {2026},
  doi = {10.1111/cpr.70141}
}
Start for free →